Jane Street
VTAE

Jane Street’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Jane Street’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-35,224
Closed -$234K – 4942
2016
Q1 		$234K Buy
+35,224
New +$320K ﹤0.01% 3510

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Jane Street's VTAE Position: Q2 2016 in Review

Jane Street sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q2 2016, closing a stake of 35,224 shares — an estimated $234K sold.

Jane Street first reported a position in VTAE in Q1 2016 and held it in 1 quarter. The position peaked at $234K in Q1 2016. 71 funds tracked by Wall St. Rank hold VTAE as of Q2 2016.

  • Jane Street reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q2 2016 after selling out during the quarter.
  • Jane Street sold 35,224 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q2 2016, an estimated $234K.
  • Jane Street first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2016 and held it in 1 quarter.
  • Jane Street's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $234K in Q1 2016.
  • 71 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q2 2016.

Based on Jane Street's 13F filing for Q2 2016, filed 15 Aug 2016.